ISSN 2306-5559 (print)
ISSN 2410-938X (online)
ISSN 2410-938X (online)
отсутствует
Serik T. TILEUOV1, http://orcid.org/0000-0003-1786-0720
Auyeskhan Т. DZHUMABEKOV2, https://orcid.org/0000-0002-3502-4411
Bolatbek B. BAIMAKHANOV1, https://orcid.org/0000-0003-0049-5886
Maksat O. DOSKHANOV1, http://orcid.org/0000-0003-0167-9863
Shokan А. KANIYEV1, https://orcid.org/0000-0002-1288-0987
Zhambyl R. OSPAN1, https://orcid.org/0000-0001-6803-5806
Evgeniy А. ENIN1, https://orcid.org/0000-0001-9450-0599
Magzhan Q. TURSYNBAI1, http://orcid.org/0009-0000-2261-7181
REFERENCES1. Ziegler KM, Nakeeb A, Pitt HA et al: Pancreatic surgery: Evolution at a high-volume center. Surgery 2010;148:702–709.2. Serrano PE, Cleary SP, Dhani N et al: Improved long-term outcomes after resection of pancreatic adenocarcinoma: A comparison between two time periods. Ann Surg Oncol 2015;22:1160–1167.3. Fish JC, Smith lB, Williams RD: Digestive function after radical pancreaticoduodenectomy. Am J Surg 1969;117:40–45.4. Ghaneh P, Neoptolemos JP: Pancreatic exocrine insufficiency following pancreatic resection. Digestion 1999;60:104–110.5. Sikkens EC, Cahen Dl, de Wit J et al: Prospective assessment of the influence of pancreatic cancer resection on exocrine pancreatic function. Br J Surg 2014;101:109–113.6. Nomura R, Ishizaki y, Suzuki K et al: Development of hepatic steatosis after pancreatoduodenectomy. AJR 2007;189:1484–1488.7. Kato H, Isaji S, Azumi y et al: Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: Proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci 2010;17:296–304.8. Yu HH, Shan yS, lin PW: Effect of pancreaticoduodenectomy on the course of hepatic steatosis. World J Surg 2010;34:2122–2127.9. Song SC, Choi SH, Choi DW et al: Potential risk factors for nonalcoholic steatohepatitis related to pancreatic secretions following pancreaticoduodenectomy. World J Gastroenterol 2011;17:3716–3723.10. Tanaka N, Horiuchi A, yokoyama T et al: Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol 2011;46:758–768.11. Okamura y, Sugimoto H, yamada S et al: Risk factors for hepatic steatosis after pancreatectomy: A retrospective observational cohort study of the importance of nutritional management. Pancreas 2012;41:1067–1072.12. Ito y, Kenmochi T, Shibutani S et al: Evaluation of predictive factors in patients with nonalcoholic fatty liver disease after pancreaticoduodenectomy. Am Surg 2014;80:500–504.13. Nakagawa N, Murakami y, uemura K et al: Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency. J Surg Oncol 2014;110:720–726.14. Sato R, Kishiwada M, Kuriyama N et al: Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2014;21:562–57215. Tomimaru Y, Takeda Y, Kobayashi S, Marubashi S, Lee CM, Tanemura M, et al. Comparison of postoperative morphological changes in remnant pancreas between pancreaticojejunostomy and pancreaticogastrostomy after pancreaticoduodenectomy. Pancreas. 2009;38(2):203–7.16. Tanaka N, Horiuchi A, Yokoyama T, et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol. 2011;46:758–768.17. Nirei K, Ogihara N, Kawamura W, et al. Rapid recovery from acute liver failure secondary to pancreatoduodenectomy-related non-alcoholic steatohepatitis. Case Rep Gastroenterol. 2013;7:49–55.18. Kato H, Isaji S, Azumi Y, et al. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci. 2010;17:296–304.19. Nakagawa N, Murakami Y, Uemura K, et al. Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency. J Surg Oncol. 2014; 110:720–726.20. Kang CM, Lee JH. Pathophysiology after pancreaticoduodenectomy. World J Gastroenterol 2015;21:5794–5804.21. Nagai M, Sho M, Satoi S, et al. Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2014;21:186–192.22. Tanaka N, Takahashi S, Fang ZZ, et al. Role of white adipose lipolysis in the development of NASH induced by methionine- and choline deficient diet. Biochim Biophys Acta. 2014;1841:1596–1607.23. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–1231.24. Sim EH, Kwon JH, Kim SY, et al. Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy. Clin Mol Hepatol. 2012;18:404–410.25. Tanaka N, Horiuchi A, Yokoyama T, et al. Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103:245–246.26. Dresler CM, Fortner JG, McDermott K, Bajorunas DR. Metabolic consequences of (regional) total pancreatectomy. Ann Surg. 1991;214:131–40.27. Nomura R, Ishizaki Y, Suzuki K, Kawasaki S. Development of hepatic steatosis after pancreatoduodenectomy. AJR Am J Roentgenol. 2007;189:1484–8.28. Day CP, James OFW. Steatohepatitis: a tale of two ‘‘hits’’? Gastroenterology. 1998;114:842–5.29. Betzel B, Drenth JP. A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease? BMC medicine 2014; 12: 152. [PMID: 25164119]30. Festi D, Schiumerini R, Marzi L, et al. Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods. Alimentary pharmacology & therapeutics 2013; 37: 392-400. [PMID: 23278163]31. Nomura R, Ishizaki Y, Suzuki K, Kawasaki S. Development of hepatic steatosis after pancreatoduodenectomy. AJR Am J Roentgenol. 2007;189:1484–8.32. Kato H, Isaji S, Azumi Y, Kishiwada M, Hamada T, Mizuno S, et al. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci. 2010;17:296–304.33. Tanaka N, Horiuchi A, Yokoyama T, Kaneko G, Horigome N, Yamaura T et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol. 2011 (Epub ahead of print).34. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–23.35. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42:44–52.36. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005;16:421–7.37. Nomura R, Ishizaki Y, Suzuki K, Kawasaki S. Development of hepatic steatosis after pancreatoduodenectomy. AJR Am J Roentgenol. 2007;189:1484–8.38. Yu HH, Shan YS, Lin PW. Effect of pancreaticoduodenectomy on the course of hepatic steatosis. World J Surg. 2010;34:2122–7.39. Kato H, Isaji S, Azumi Y, Kishiwada M, Hamada T, Mizuno S, et al. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci. 2010;17:296–304.40. Tanaka N, Horiuchi A, Yokoyama T, Kaneko G, Horigome N, Yamaura T, et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol. 2011;46:758–68.41. Murata Y, Mizuno S, Kato H, Kishiwada M, Ohsawa I, Hamada T, et al. Nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: association of pancreatic exocrine deficiency and infection. Clin J Gastroenterol. 2011;4:242–8.42. Song SC, Choi SH, Choi DW, Heo JS, Kim WS, Kim MJ. Potential risk factors for nonalcoholic steatohepatitis related to pancreatic secretions following pancreaticoduodenectomy. World J Gastroenterol. 2011;17:3716–2343. Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res. 2008;49:1068–76.44. Kato H, Isaji S, Azumi Y, Kishiwada M, Hamada T, Mizuno S, et al. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci. 2010;17:296–304. https:// doi. org/ 10. 1007/ s00534- 009- 0187-2.45. Murata Y, Mizuno S, Kato H, Kishiwada M, Ohsawa I, Hamada T, et al. Nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: association of pancreatic exocrine deficiency and infection. Clin J Gastroenterol. 2011;4:242–8. https:// doi. org/ 10. 1007/ s12328- 011- 0226-9.46. Kato K, Isaji S, Kawarada Y, Hibasami H, Nakashima K. Effect of zinc administration on pancreatic regeneration after 80% pancreatectomy. Pancreas. 1997;14:158–65. https:// doi. org/ 10. 1097/ 00006 676- 19970 3000- 00008.